Brief: Imugene Ltd Says Received US FDA Orphan Drug Designation For Vaxinia
18/09/2024 04:12
Sept 18 (Reuters) - Imugene Ltd IMU.AX :
* IMUGENE RECEIVES ORPHAN DRUG DESIGNATION FOR VAXINIA
* US FDA GRANTS CF33-HNIS (VAXINIA) ORPHAN DRUG DESIGNATION
Further company coverage: IMU.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imugene
See all newsAustralia's Imugene rises on fresh responses in blood cancer drug trial
Brief: Imugene Ltd Says Leslie Chong Resigns As CEO
Australia's Imugene loses most in over 8-years on discounted placement
Brief: Imugene To Raise A$11.12 Million Via Placement At A$0.095 Per Share
Brief: Imugene Requests Trading Halt Pending Proposed Capital Raising Announcement